# Clinical Study of NPC-12Y Gel in Patients With Skin Lesions Associated With TSC

> **NCT05495425** · PHASE3 · COMPLETED · sponsor: **Nobelpharma** · enrollment: 43 (actual)

## Conditions studied

- Tuberous Sclerosis Complex

## Interventions

- **DRUG:** NPC-12Y gel
- **DRUG:** NPC-12Y placebo gel

## Key facts

- **NCT ID:** NCT05495425
- **Lead sponsor:** Nobelpharma
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-06-01
- **Primary completion:** 2024-10-30
- **Final completion:** 2024-10-30
- **Target enrollment:** 43 (ACTUAL)
- **Last updated:** 2024-11-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05495425

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05495425, "Clinical Study of NPC-12Y Gel in Patients With Skin Lesions Associated With TSC". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT05495425. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*